Point72 Asset Management
WVE icon

Point72 Asset Management’s Wave Life Sciences WVE Stock Holding History

Point72 Asset Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.63M Buy
+1,484,989
New +$9.85M 0.01% 1375
2025
Q4 		– Sell
-663,967
Closed -$4.86M – 4212
2025
Q3 		$4.86M Buy
+663,967
New +$5.37M 0.01% 1081
2024
Q4 		– Sell
-28,096
Closed -$230K – 2511
2024
Q3 		$230K Sell
28,096
-87,382
-76% -$522K ﹤0.01% 1759
2024
Q2 		$576K Sell
115,478
-1,859,259
-94% -$10.6M ﹤0.01% 1406
2024
Q1 		$12.2M Sell
1,974,737
-1,238,763
-39% -$6.2M 0.03% 644
2023
Q4 		$16.2M Buy
+3,213,500
New +$17.2M 0.04% 510
2023
Q2 		– Sell
-15,800
Closed -$68.4K – 2859
2023
Q1 		$68.4K Sell
15,800
-47,800
-75% -$219K ﹤0.01% 1711
2022
Q4 		$445K Sell
63,600
-970,600
-94% -$4.47M ﹤0.01% 1162
2022
Q3 		$3.73M Buy
+1,034,200
New +$3.42M 0.01% 805
2021
Q2 		– Sell
-849,109
Closed -$4.76M – 1192
2021
Q1 		$4.76M Buy
+849,109
New +$8.16M 0.02% 581
2020
Q3 		– Sell
-286,116
Closed -$2.98M – 1119
2020
Q2 		$2.98M Buy
+286,116
New +$2.69M 0.02% 547
2020
Q1 		– Sell
-158,400
Closed -$1.27M – 1119
2019
Q4 		$1.27M Buy
158,400
+113,400
+252% +$2.78M 0.01% 684
2019
Q3 		$924K Buy
45,000
+1,500
+3% +$34.4K 0.01% 706
2019
Q2 		$1.14M Sell
43,500
-538,811
-93% -$15.1M 0.01% 756
2019
Q1 		$22.6M Buy
582,311
+92,499
+19% +$3.75M 0.1% 228
2018
Q4 		$20.6M Buy
489,812
+89,812
+22% +$3.99M 0.1% 251
2018
Q3 		$20M Buy
400,000
+50,000
+14% +$2.26M 0.08% 302
2018
Q2 		$13.4M Buy
350,000
+307,700
+727% +$13.2M 0.05% 378
2018
Q1 		$1.7M Sell
42,300
-57,700
-58% -$2.43M 0.01% 754
2017
Q4 		$3.51M Sell
100,000
-528,912
-84% -$15.4M 0.02% 649
2017
Q3 		$13.7M Buy
+628,912
New +$12.6M 0.06% 337

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Point72 Asset Management's WVE Position: Q2 2026 in Review

Point72 Asset Management opened a new position in Wave Life Sciences (WVE) in Q2 2026: 1,484,989 shares worth $8.63M. The stake represents 0.01% of the portfolio and ranks #1375 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in WVE as recently as Q3 2025.

Point72 Asset Management first reported a position in WVE in Q3 2017 and has held it in 21 quarters since. The position peaked at $22.6M in Q1 2019. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Point72 Asset Management held 1,484,989 shares of Wave Life Sciences worth $8.63M as of Q2 2026.
  • Wave Life Sciences was a new Point72 Asset Management position in Q2 2026.
  • Wave Life Sciences made up 0.01% of Point72 Asset Management's portfolio in Q2 2026, its #1375 holding.
  • Point72 Asset Management first reported a position in Wave Life Sciences in Q3 2017 and has held it in 21 quarters since.
  • Point72 Asset Management's Wave Life Sciences position peaked at $22.6M in Q1 2019.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.